Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Budman

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of vinzolidineW Kreis, D R Budman, P Schulman, et al.
Cancer Investigation|December 7, 2000
Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitroD R Budman, A Calabro, L G Wang, et al.
Journal of Clinical Gastroenterology|October 1, 1987
Flow cytometry. A new technique in the diagnosis of malignant ascitesG S Weissman, M J McKinley, D R Budman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsW Kreis, D R Budman, V Vinciguerra, et al.
Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
Cancer Investigation|January 1, 1990
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443D R Budman, A H Korzun, J Aisner, et al.
Arthritis and Rheumatism|April 1, 1977
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLED R Budman, E B Merchant, A D Steinberg, et al.
American Journal of Hematology|January 12, 1999
Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimenR L Bayer, S M Lichtman, S L Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group BD R Budman, G R Petroni, J L Johnson, et al.
Cancer Research|March 1, 1988
Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hoursW Kreis, K Chan, D R Budman, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of vinzolidineW Kreis, D R Budman, P Schulman, et al.
Cancer Investigation|December 7, 2000
Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitroD R Budman, A Calabro, L G Wang, et al.
Journal of Clinical Gastroenterology|October 1, 1987
Flow cytometry. A new technique in the diagnosis of malignant ascitesG S Weissman, M J McKinley, D R Budman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsW Kreis, D R Budman, V Vinciguerra, et al.
Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
Cancer Investigation|January 1, 1990
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443D R Budman, A H Korzun, J Aisner, et al.
Arthritis and Rheumatism|April 1, 1977
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLED R Budman, E B Merchant, A D Steinberg, et al.
American Journal of Hematology|January 12, 1999
Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimenR L Bayer, S M Lichtman, S L Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group BD R Budman, G R Petroni, J L Johnson, et al.
Cancer Research|March 1, 1988
Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hoursW Kreis, K Chan, D R Budman, et al.
Pageof 11